Adverse Outcome Pathways (AOPs) — The latest news about safe, sustainable and bio-based materials and products

Vireo Publishes “Translating Scientific Advances in the AOP Framework to Decision Making for Nanomaterials”

Vireo Advisors, as part of a collaboration with SmartNanoTox, a leading EU-funded nanosafety consortia published “Translating Scientific Advances in the AOP Framework to Decision Making for Nanomaterials”; available in the journal Nanomaterials.

Nanomaterials, Risk Analysis, Safety, NanoEHS NewsJames EdeJuly 8, 2020AOP frameworks, Vireo Advisors, OECD Working Party on Manufactured Nanomaterials (WPMN), Nanomaterials Journal, Adverse Outcome Pathways (AOPs), manufactured nanomaterials, manufactured nanomaterial risk assessment, “Advancing AOP Development for Nanomaterial Risk Assessment and Categorization”Comment

Vireo Advisors Coordinating OECD Workshop to Advance Use of Adverse Outcome Pathways (AOP) for Nanomaterial Risk Assessment

Vireo Advisors is collaborating with Health Canada and two European Horizon2020 projects to coordinate two back-to-back workshops at the OECD: “Advancing Adverse Outcome Pathway (NanoAOP) Development for Nanomaterial Risk Assessment and Categorization” (NanoAOP Workshop), to be held 11 September 2019, and a stakeholder workshop organized by the EU H2020 Project Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment (PATROLS ), to be held 12 September 2019.

NanoAOP Workshop coordinated by Vireo Advisors held at NanoTox 2018- 9th International Conference on Nanotoxicology

Vireo Advisors coordinated an expert workshop during Nanotox 2018 entitled, “Advancing Adverse Outcome Pathway (AOP) Development for Nanomaterial Risk Assessment and Categorization”.

Events, Nanomaterials, Risk AnalysisJames EdeSeptember 27, 2018vireo, nanotox 2018, Nano AOP, Adverse Outcome Pathways (AOPs), European Horizon2020 Project SmartNanoTox, The Two Faces of Inflammation: Adverse vs Normal Tissue Response, Dr. Jo Anne Shatkin, Dr. James Ede, Sabina Halappanavar of Health Canada, Harold Krug of NanoCASE, David Warheit of Chemours and Dr. Bengt Fadeel of Karolinska Institute, Flemming Cassee (National Institute for Public Health and the Environment), Tobias Stoeger (Helmholtz Center), Ulla Vogel (National Research Center for the Working Environment), Dominique Lison (Universite Catholique du Lovain), v, Vicki Stone (Heriot-Watt University), Robert Landsiedel (BASF SE), Tom van Teunenbroek (Ministry of Infrastructure and Environment), Andrea Haase (German Federal Institute for Risk Assessment), Susan Dekkers [Institute for Public Health and the Environment (RIVM), Risk Assessor Human Exposure and Toxicology]Comment

Vireo Advisor's Kimberly Ong to Present Work of NanoAOP Project at Nano Canada 2017

Dr. Kimberly Ong of Vireo Advisors will present Vireo’s ongoing collaborative work* entitled, "Advancing Adverse Outcome Pathways as a Tool for the Risk Assessment of Nanomaterials – the NanoAOP Project", during NanoCanada's first national conference: Converging on Nanomanufacturing from September 25-26, 2017 in Montréal, Canada.